Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • OncoDxRx’s PGA — the world-first platform bridging cell-free mRNA expression to therapies

    Mar 7, 2023, 09:26 AM by
    A Pharmacogenomic Breakthrough Translating Personalized Gene Expression to Therapies
    Full story
  • Pharma-Diagnostics Lockstep: How Two Industries Can Work Together for Precision Medicine

    Mar 7, 2023, 09:14 AM by User Not Found
    Bio-IT World | Sarah Hersey, VP of Precision Medicine at Bristol Myers Squibb, gave a balanced view of the challenges and opportunities facing precision medicine in her keynote address at the Molecular & Precision Medicine Tri-Conference in San Diego this week. After her presentation she was joined by others in the space to talk about the future for diagnostics and precision medicine.
    Full story
  • PubHive Integrates with Microsoft Azure Active Directory

    Mar 6, 2023, 14:14 PM by
    PubHive customers can now enable users to automatically sign-on to the PubHive Navigator cloud software platform using secure single sign-on technology powered by Microsoft Azure Active Directory
    Full story
  • Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research

    Mar 6, 2023, 14:10 PM by
    Full story
  • Alfa Chemistry to Present at the Upcoming ACS Spring 2023 Conference

    Mar 6, 2023, 14:07 PM by
    Alfa Chemistry, a chemical company focused on supplying high-quality chemicals and materials for both academia and the industry, today announced that members of its Senior Management Team are scheduled to participate in the upcoming ACS Spring 2023 Conference in March at Indiana Convention Center, located in 100 S Capitol Ave, Indianapolis, IN 46225.
    Full story
  • Alfa Chemistry Announces to Participate in the Upcoming Pittcon Conference & Exposition 2023

    Mar 3, 2023, 10:13 AM by
    The New York-based chemical vendor Alfa Chemistry recently announced its attendance at the upcoming Pittcon Conference & Exposition 2023. This five-day event will take place at Pennsylvania Convention Center from 18th – 22nd March 2023.
    Full story
  • Creative Proteomics Enhances Your Project with Cell Surface Proteomics Service

    Mar 3, 2023, 10:12 AM by
    Full story
  • Creative Proteomics Cytokine Boosts Cancer Research with Cancer Cytokines Assay

    Mar 3, 2023, 10:12 AM by
    Full story
  • Pronalyse Announces the Launch of Epitope Mapping Service Utilizing HDX-MS Technology

    Mar 3, 2023, 10:11 AM by
    Full story
  • Cancer Support Community and Equiva Health partner to create new industry standard for digital cancer support

    Mar 3, 2023, 10:11 AM by
    Equiva Health recently announced a partnership with the Cancer Support Community—the largest professionally led non-profit cancer support network—to launch a pilot program in Minnesota to bring a new, digital model of cancer care to communities that lack access. CSC will use Equiva’s health relationship management platform to bring CSC’s services and resources to patients via broadband-enabled tablets. Those who qualify will also be able to apply for the FCC’s Affordable Connectivity Program via Equiva and ISP provider Infiniti Mobile, providing low to no-cost broadband connection to support access to CSC's resources Overall this partnership is an effort to bring digital cancer care and telemedicine services to underserved communities to improve health equity among these populations.
    Full story
  • Form Bio Names Linda Murray as Chief Financial Officer

    Mar 2, 2023, 14:38 PM by
    Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer.
    Full story
  • Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

    Mar 2, 2023, 14:38 PM by
    Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
    Full story
  • BRIM Biotechnology announces first patient enrollment in pivotal Phase 3 clinical trial of BRM421 for Dry Eye Disease

    Mar 2, 2023, 10:08 AM by
    BRIM Biotechnology Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that the first patient has been enrolled in its Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED).
    Full story
  • CD Formulation Upgrades Its Database of Pharmaceutical Excipients, Cosmetic Ingredients, and Food Ingredients

    Mar 2, 2023, 10:08 AM by
    Full story
  • Common Food Additives: Preservatives, Thickeners, and Sweeteners

    Mar 2, 2023, 10:08 AM by
    Full story
  • Fascinating Coordination Complexes and Their Applications

    Mar 2, 2023, 10:06 AM by
    Coordination chemistry investigates the characteristics of coordination compounds formed by the interaction between metal atoms or ions and inorganic, organic ions or molecules, as well as their bonding, structure, reaction, classification, and preparation.
    Full story
  • Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials

    Mar 2, 2023, 10:05 AM by
    Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.
    Full story
  • Therapeutic Targets For MS Found In The Gut

    Mar 2, 2023, 01:00 AM by User Not Found
    Bio-IT World | Neuroscientists at the University of Virginia have succeeded in alleviating the harmful inflammation of multiple sclerosis in a mouse model of the disease by modulating the gut microbiome to disable a key immune regulator known as aryl hydrocarbon receptor.
    Full story
  • CD Biosciences Provides Peptidomimetic Development Services to FacilitateTherapeutic Development

    Mar 1, 2023, 09:55 AM by
    Full story
  • CD Biosciences Supplies Services for Single-cell Transcriptome Sequencing and Analysis for TME Research

    Mar 1, 2023, 09:54 AM by
    Full story
  • «
  • 111
  • 112
  • 113
  • 114
  • 115 (current)
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy